PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The American Journal of Respiratory and Critical Care Medicine

Press Release
Written by Jamison Wright

https://news.puretechhealth.com/news-releases/news-release-details/puretech-announces-publication-phase-2b-elevate-ipf-trial

Jamison Wright https://jamisonwright.com
Previous

Deupirfenidone Compared with Pirfenidone and Placebo in Idiopathic Pulmonary Fibrosis (ELEVATE-IPF): a Phase 2b Randomized Placebo-Controlled Trial Open Access
Next

PureTech Announces Orphan Drug Designations Granted by the U.S. Food and Drug Administration and European Commission for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis